NO20000484L - Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel - Google Patents

Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Info

Publication number: NO20000484L
Authority: NO; Norway
Prior art keywords: crystalline; füä1; ethylü; dibenzoäb; hydroxyethoxy
Prior art date: 1997-08-01

Application number

NO20000484A

Other languages

English (en)

Other versions

NO20000484D0 (no

Inventor

Evan William Snape

Original Assignee

Zeneca Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-08-01

Filing date

2000-01-31

Publication date

2000-03-16

2000-01-31 Application filed by Zeneca Ltd filed Critical Zeneca Ltd

2000-01-31 Publication of NO20000484D0 publication Critical patent/NO20000484D0/no

2000-03-16 Publication of NO20000484L publication Critical patent/NO20000484L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D281/16—[b, f]-condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Psychiatry (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Glass Compositions (AREA)
Iron Core Of Rotating Electric Machines (AREA)
Liquid Crystal Substances (AREA)

NO20000484A 1997-08-01 2000-01-31 Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel NO20000484L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9716161.6A GB9716161D0 (en)	1997-08-01	1997-08-01	Process
PCT/GB1998/002260 WO1999006381A1 (en)	1997-08-01	1998-07-28	A crystalline dibenzothiazepine derivative and its use as an antipsychotic agent

Publications (2)

Publication Number	Publication Date
NO20000484D0 NO20000484D0 (no)	2000-01-31
NO20000484L true NO20000484L (no)	2000-03-16

Family

ID=10816746

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20000484A NO20000484L (no)	1997-08-01	2000-01-31	Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel

Country Status (31)

Country	Link
US (2)	US6372734B1 (no)
EP (2)	EP1589008B1 (no)
JP (2)	JP2001512109A (no)
KR (1)	KR20010022241A (no)
CN (1)	CN1125058C (no)
AT (2)	ATE444959T1 (no)
AU (1)	AU739255B2 (no)
BG (1)	BG64796B1 (no)
BR (1)	BR9811061A (no)
CA (1)	CA2295792C (no)
CY (2)	CY2200161T2 (no)
CZ (1)	CZ299225B6 (no)
DE (4)	DE69842104D1 (no)
EE (1)	EE04550B1 (no)
ES (2)	ES2296575T3 (no)
GB (2)	GB9716161D0 (no)
HU (1)	HU228620B1 (no)
ID (1)	ID24219A (no)
IL (1)	IL133618A (no)
MY (1)	MY120999A (no)
NO (1)	NO20000484L (no)
NZ (1)	NZ501914A (no)
PL (1)	PL338384A1 (no)
PT (2)	PT1000043E (no)
RU (1)	RU2224754C2 (no)
SI (2)	SI1000043T1 (no)
SK (1)	SK287145B6 (no)
TR (1)	TR200000848T2 (no)
TW (1)	TW533207B (no)
WO (1)	WO1999006381A1 (no)
ZA (1)	ZA986904B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2479668A1 (en) *	2002-03-20	2003-10-02	Teva Pharmaceutical Industries Ltd.	Crystalline forms of quetiapine hemifumarate
WO2004076431A1 (en) *	2003-02-22	2004-09-10	Teva Pharmaceutical Industries Ltd.	Synthesis of quetiapine and pharmaceutically acceptable salts thereof
US7238686B2 (en) *	2003-03-03	2007-07-03	Hetero Drugs Limited	Polymorphs of quetiapine fumarate
EP1611138A1 (en) *	2003-04-07	2006-01-04	Hetero Drugs Limited	A novel crystalline form of dorzolamide hydrochloride
ES2223294B2 (es)	2003-08-08	2005-10-01	Vita Cientifica, S.L.	Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) *	2004-09-13	2006-04-20	Gabbey Lawrence W	Oil cooler with integral filter
WO2006035293A1 (en) *	2004-09-27	2006-04-06	Ranbaxy Laboratories Limited	Polymorphic forms of quetiapine hemifumarate
GB0425729D0 (en) *	2004-11-23	2004-12-22	Pliva Res & Dev Ltd	Heterocyclic compounds
WO2006056772A2 (en) *	2004-11-23	2006-06-01	Pliva Hrvatska D.O.O.	Salts of quetiapine
ES2234447B1 (es) *	2005-03-07	2006-03-01	Union Quimico-Farmaceutica S.A.	Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
CA2603795A1 (en) *	2005-04-14	2006-10-26	Teva Pharmaceutical Industries Ltd.	Process for preparing quetiapine fumarate
US20070072840A1 (en) *	2005-05-30	2007-03-29	Pandya Bhargav	Polymorphic forms of quetiapine
WO2007036599A1 (en)	2005-09-30	2007-04-05	Fermion Oy	New crystallization process of quetiapine hemifumarate
EP1948628A1 (en) *	2005-10-28	2008-07-30	Fermion Oy	Quetiapine hemifumarate purification by crystallization
JP2009516708A (ja) *	2005-11-18	2009-04-23	アストラゼネカ・アクチエボラーグ	液体製剤
WO2007062336A2 (en) *	2005-11-18	2007-05-31	Astrazeneca Ab	Salt forms
JP2009516707A (ja) *	2005-11-18	2009-04-23	アストラゼネカ・アクチエボラーグ	固形製剤
EP1951257A4 (en) *	2005-11-18	2008-11-05	Astrazeneca Ab	CRYSTALLINE FORMS
US8389510B2 (en) *	2005-11-18	2013-03-05	Astrazeneca Ab	Crystalline forms
CZ300451B6 (cs) *	2006-07-03	2009-05-20	Farmak, A. S.	Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) *	2006-10-20	2008-06-05	Concert Pharmaceuticals Inc.	Dibenzothiazepine derivatives
ATE480227T1 (de)	2007-02-14	2010-09-15	Lesvi Laboratorios Sl	Pharmazeutische zusammensetzungen mit quetiapinfumarat
WO2008121415A2 (en) *	2007-03-29	2008-10-09	Teva Pharmaceutical Industries Ltd.	Improved process for preparing quetiapine fumarate
US8101597B2 (en) *	2007-05-07	2012-01-24	Actavis Group Ptc Ehf	Quetiapine salts and their polymorphs
US20090082334A1 (en) *	2007-09-25	2009-03-26	Protia, Llc	Deuterium-enriched quetiapine
US8461145B2 (en) *	2007-12-05	2013-06-11	Janssen Pharmaceutica Nv	Dibenzoazepine and dibenzooxazepine TRPA1 agonists
SI2262486T1 (sl)	2008-08-01	2013-04-30	Krka, Tovarna Zdravil, D.D., Novo Mesto	Sestavek kvetiapina
WO2010033270A1 (en) *	2008-09-17	2010-03-25	Auspex Pharmaceuticals, Inc.	Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
JP2012519683A (ja)	2009-03-04	2012-08-30	ランバクシーラボラトリーズリミテッド	フマル酸クエチアピンの調製方法
EP3789500A1 (en)	2011-08-12	2021-03-10	QIAGEN GmbH	Method for isolating nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE787249A (fr)	1971-08-05	1973-02-05	Squibb & Sons Inc	Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) *	1986-03-27	1986-04-30	Ici America Inc	Thiazepine compounds
GB8705574D0 (en) *	1987-03-10	1987-04-15	Ici Plc	Preparation of thiazepine compound

1997
- 1997-08-01 GB GBGB9716161.6A patent/GB9716161D0/en active Pending
1998
- 1998-07-10 GB GBGB9814882.8A patent/GB9814882D0/en active Pending
- 1998-07-28 RU RU2000105271/04A patent/RU2224754C2/ru not_active IP Right Cessation
- 1998-07-28 CN CN98807572A patent/CN1125058C/zh not_active Expired - Fee Related
- 1998-07-28 DE DE69842104T patent/DE69842104D1/de not_active Expired - Lifetime
- 1998-07-28 TW TW087112313A patent/TW533207B/zh not_active IP Right Cessation
- 1998-07-28 ES ES98936529T patent/ES2296575T3/es not_active Expired - Lifetime
- 1998-07-28 PL PL98338384A patent/PL338384A1/xx not_active Application Discontinuation
- 1998-07-28 DE DE05011169T patent/DE05011169T1/de active Pending
- 1998-07-28 TR TR2000/00848T patent/TR200000848T2/xx unknown
- 1998-07-28 SK SK130-2000A patent/SK287145B6/sk not_active IP Right Cessation
- 1998-07-28 DE DE69841216T patent/DE69841216D1/de not_active Expired - Lifetime
- 1998-07-28 AU AU85498/98A patent/AU739255B2/en not_active Ceased
- 1998-07-28 PT PT98936529T patent/PT1000043E/pt unknown
- 1998-07-28 BR BR9811061-6A patent/BR9811061A/pt not_active Application Discontinuation
- 1998-07-28 AT AT98936529T patent/ATE444959T1/de active
- 1998-07-28 JP JP2000505140A patent/JP2001512109A/ja active Pending
- 1998-07-28 IL IL13361898A patent/IL133618A/en not_active IP Right Cessation
- 1998-07-28 AT AT05011169T patent/ATE496037T1/de active
- 1998-07-28 ID IDW20000029A patent/ID24219A/id unknown
- 1998-07-28 EE EEP200000062A patent/EE04550B1/xx not_active IP Right Cessation
- 1998-07-28 SI SI9830923T patent/SI1000043T1/sl unknown
- 1998-07-28 HU HU0002663A patent/HU228620B1/hu not_active IP Right Cessation
- 1998-07-28 EP EP05011169A patent/EP1589008B1/en not_active Expired - Lifetime
- 1998-07-28 CA CA002295792A patent/CA2295792C/en not_active Expired - Fee Related
- 1998-07-28 PT PT05011169T patent/PT1589008E/pt unknown
- 1998-07-28 US US09/463,452 patent/US6372734B1/en not_active Expired - Lifetime
- 1998-07-28 ES ES05011169T patent/ES2296568T3/es not_active Expired - Lifetime
- 1998-07-28 CZ CZ20000341A patent/CZ299225B6/cs not_active IP Right Cessation
- 1998-07-28 KR KR1020007000814A patent/KR20010022241A/ko not_active Ceased
- 1998-07-28 WO PCT/GB1998/002260 patent/WO1999006381A1/en not_active Ceased
- 1998-07-28 SI SI9830929T patent/SI1589008T1/sl unknown
- 1998-07-28 NZ NZ501914A patent/NZ501914A/en not_active IP Right Cessation
- 1998-07-28 DE DE98936529T patent/DE98936529T1/de active Pending
- 1998-07-28 EP EP98936529A patent/EP1000043B1/en not_active Expired - Lifetime
- 1998-07-29 MY MYPI98003471A patent/MY120999A/en unknown
- 1998-07-31 ZA ZA986904A patent/ZA986904B/xx unknown
2000
- 2000-01-31 NO NO20000484A patent/NO20000484L/no unknown
- 2000-02-22 BG BG104176A patent/BG64796B1/bg unknown
2002
- 2002-03-21 US US10/101,948 patent/US20020147186A1/en not_active Abandoned
2008
- 2008-03-04 CY CY20082200004T patent/CY2200161T2/el unknown
- 2008-03-04 CY CY20082200005T patent/CY2200162T2/el unknown
- 2008-12-09 JP JP2008313248A patent/JP2009102345A/ja active Pending

Also Published As

Publication number	Publication date
KR20010022241A (ko)	2001-03-15
ATE496037T1 (de)	2011-02-15
GB9814882D0 (en)	1998-09-09
DE05011169T1 (de)	2008-11-06
EE200000062A (et)	2000-10-16
ID24219A (id)	2000-07-13
ES2296568T1 (es)	2008-05-01
ATE444959T1 (de)	2009-10-15
CY2200161T2 (el)	2010-07-28
BG64796B1 (bg)	2006-04-28
GB9716161D0 (en)	1997-10-08
DE69842104D1 (de)	2011-03-03
CZ2000341A3 (cs)	2000-05-17
ES2296575T1 (es)	2008-05-01
SI1589008T1 (sl)	2011-04-29
CA2295792A1 (en)	1999-02-11
NO20000484D0 (no)	2000-01-31
ES2296575T3 (es)	2010-02-05
CN1125058C (zh)	2003-10-22
DE98936529T1 (de)	2008-11-20
JP2009102345A (ja)	2009-05-14
JP2001512109A (ja)	2001-08-21
WO1999006381A1 (en)	1999-02-11
HUP0002663A2 (hu)	2001-09-28
ES2296568T3 (es)	2011-05-06
US20020147186A1 (en)	2002-10-10
CY2200162T2 (el)	2010-07-28
AU739255B2 (en)	2001-10-04
AU8549898A (en)	1999-02-22
SI1000043T1 (sl)	2010-01-29
HU228620B1 (en)	2013-04-29
ZA986904B (en)	1999-02-01
MY120999A (en)	2005-12-30
HK1029992A1 (en)	2001-04-20
CZ299225B6 (cs)	2008-05-21
EP1000043A1 (en)	2000-05-17
CA2295792C (en)	2007-04-17
SK1302000A3 (en)	2000-06-12
EP1589008A1 (en)	2005-10-26
HUP0002663A3 (en)	2001-10-29
BG104176A (en)	2000-08-31
EP1000043B1 (en)	2009-10-07
NZ501914A (en)	2001-09-28
CN1265101A (zh)	2000-08-30
PT1000043E (pt)	2009-11-30
PT1589008E (pt)	2011-03-23
TR200000848T2 (tr)	2000-08-21
EP1589008B1 (en)	2011-01-19
HK1081962A1 (en)	2006-05-26
IL133618A (en)	2004-02-08
IL133618A0 (en)	2001-04-30
DE69841216D1 (de)	2009-11-19
BR9811061A (pt)	2000-09-19
PL338384A1 (en)	2000-10-23
RU2224754C2 (ru)	2004-02-27
SK287145B6 (sk)	2010-01-07
US6372734B1 (en)	2002-04-16
TW533207B (en)	2003-05-21
EE04550B1 (et)	2005-10-17

Publication	Publication Date	Title
NO20000484D0 (no)	2000-01-31	Krystallinsk dibenzotiazepinderivat og anvendelse derav som et antipsykotisk middel
AU697679B2 (en)	1998-10-15	Treatment of tinnitis using neuroprotective agents
FI20031381A7 (fi)	2003-09-25	Menetelmä antihistamiinisten 4-difenyylimetyylipiperidiinijohdannaisten valmistamiseksi
AU2002213515A1 (en)	2002-05-21	An apparatus convertible to a chair or treatment table
ES2182079T3 (es)	2003-03-01	Composiciones farmaceuticas de liberacion sostenida que contienen un derivado de dibenzotiazepina.
AU2001295926A1 (en)	2002-04-22	Process for producign optically active ethyl
NO931534L (no)	1993-11-15	Sulfonylbenzylsubstituerte benzo- og pyridopyridoner
NO303641B1 (no)	1998-08-10	Optisk aktive benzotiepinderivater, mellomprodukter for deres fremstilling og deres anvendelse
NO962717D0 (no)	1996-06-27	Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister
DK1075471T3 (da)	2005-01-17	Idolylderivater som serotonerge midler
AU4009497A (en)	1998-02-10	Substituted pyrazolyl-pyrazole derivatives, process for their preparation nd their use as agents with a herbicidal effect
ES2091285T3 (es)	1996-11-01	2-hidroxi-1,2,3-propanotricarboxilato de 3-((5-metil-2-furanil)-metil)-n-(4-piperidinil)-3h-imidazo-(4,5-b)-piridin-2-amina.
AU7177496A (en)	1997-05-22	Piperidinylethylamide derivatives as serotonergic agents
PT1019521E (pt)	2006-09-29	Um metodo para a biotransformacao de compostos de colchicona nos derivados de 3-glicosil correspondentes
DK0789658T3 (da)	1999-09-13	Styreindretning til at opnå optimal anvendelse af den energi, der frembringes af et fartøjs hovedenergikilde
AU7641291A (en)	1992-06-18	Composition for disinfecting water by the electrochlorination process and use of this composition
AU7379794A (en)	1995-02-28	Aza-5,5-fused heterocyclic acids as leukotriene antagonists
DK0980383T3 (da)	2003-04-14	Farmaceutisk acceptable salte af 3-hydroxy-østr-5(10)-en-17-on-3-sulfat aktive som østrogener
AU2002339219A1 (en)	2003-04-07	Improved process for the preparation of optically active phenoxazine derivatives as antidiabetic agents
IT9022077A0 (it)	1990-11-15	Procedimento per il recupero dei residui stirenici solforati.
IT236181Y1 (it)	2000-07-26	Punta perfezionata per chirurgia oculistica,in particolare per larimozione della cataratta
SE9602476D0 (sv)	1996-06-24	Process for the preparation of organic salts of N'N -diacetylcystine
SE9602418D0 (sv)	1996-06-18	Process for the preparation of organic salts of N'N-diacetylcystine
ITRM940833A0 (it)	1994-12-23	"cerotto per assorbimento transcutaneo a rilascio controllato di fitoassociazione eventualmente arricchita"